


Searching News Database: Occluder
HSMN NewsFeed - 8 Feb 2022
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
HSMN NewsFeed - 8 Sep 2021
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
HSMN NewsFeed - 25 Aug 2021
Baylis Medical Announces First Clinical Case Using the VersaCross(R) Large Access Solution in Canada
Baylis Medical Announces First Clinical Case Using the VersaCross(R) Large Access Solution in Canada
HSMN NewsFeed - 16 Aug 2021
Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
HSMN NewsFeed - 20 Apr 2021
Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept(TM) ASD Occluder
Newly Formed Company, atHeart Medical, Aims to Evolve Septal Closure with the reSept(TM) ASD Occluder
HSMN NewsFeed - 18 Dec 2020
Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation
Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation
HSMN NewsFeed - 17 Sep 2019
Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
HSMN NewsFeed - 4 Jun 2019
GORE(R) CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects
GORE(R) CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects
HSMN NewsFeed - 2 May 2018
Nobles Medical Launches Sales of its NobleStitch(TM) EL for PFO Closure in Spain
Nobles Medical Launches Sales of its NobleStitch(TM) EL for PFO Closure in Spain
HSMN NewsFeed - 3 Apr 2018
FDA Approves GORE(R) CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
FDA Approves GORE(R) CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
HSMN NewsFeed - 18 Jan 2013
St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention
St. Jude Medical Receives CE Mark of Next-Generation Cardiac Device for Stroke Prevention
HSMN NewsFeed - 19 Oct 2012
First Patient Enrolled in GORE(R) Septal Occluder Clinical Study for Atrial Septal Defect
First Patient Enrolled in GORE(R) Septal Occluder Clinical Study for Atrial Septal Defect
HSMN NewsFeed - 19 Mar 2009
Occlutech Obtains Favourable Ruling in Proceedings Initiated by AGA Medical
Occlutech Obtains Favourable Ruling in Proceedings Initiated by AGA Medical
HSMN NewsFeed - 10 Mar 2009
Gore Announces First Patient Treated With Recently-Cleared GORE Flow Reversal System
Gore Announces First Patient Treated With Recently-Cleared GORE Flow Reversal System
HSMN NewsFeed - 6 Jan 2009
German Appeals Court Rules in Favor of AGA Medical in Patent Infringement Lawsuit Against Occlutech
German Appeals Court Rules in Favor of AGA Medical in Patent Infringement Lawsuit Against Occlutech
HSMN NewsFeed - 30 Oct 2008
Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
HSMN NewsFeed - 5 May 2008
Gore Receives Approval From FDA For Unique Patent Foramen Ovale Stroke Study
Gore Receives Approval From FDA For Unique Patent Foramen Ovale Stroke Study
HSMN NewsFeed - 11 Feb 2008
AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II
AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II
HSMN NewsFeed - 3 Oct 2007
FDA Approves GORE HELEX Septal Occluder for Treatment of Atrial Septal Defect
FDA Approves GORE HELEX Septal Occluder for Treatment of Atrial Septal Defect
HSMN NewsFeed - 10 Sep 2007
AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Additional items found! 15
Members Archive contains
15 additional stories matching:
Occluder
(Password required)
Occluder
(Password required)
